Patients with heart disease in Latin America appear to receive less aggressive treatment and face mortality rates nearly twice as high as their neighbors to the north.
During the recent European Society of Cardiology meeting in Barcelona, Spain, researchers from several centers in the United States and Latin America presented findings on 585 patients treated at 72 hospitals in eight Latin American countries and 4358 patients treated at 307 hospitals in the United States and Canada. The patients were in the PURSUIT (Platelet Glycoprotein Iib/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy) clinical trial.
Voelker R. Heart Disease in Latin America. JAMA. 1999;282(14):1322. doi:10.1001/jama.282.14.1322-JWM90008-3-1